Macrophages are pivotal components of the innate immune system, ubiquitously residing within tissues to execute core functions such as pathogen clearance, dead cell removal, and maintenance of physiological equilibrium. Despite their widespread presence, these cells manifest a remarkable ability to adapt to the microenvironment-specific demands of distinct organs while preserving a universal genetic program. The molecular underpinnings that govern this balance between specialization and shared identity, however, remained elusive until now.

Professor Thomas Marichal and his team in the Immunophysiology Laboratory at ULiège set out to elucidate these mechanisms and discovered that the transcription factor MafB serves as a master regulatory switch. Acting at the genetic level, MafB directs an extensive network of gene expression essential for driving monocytes—the precursor cells circulating in the bloodstream—toward fully mature, operational macrophages within tissues. This transition empowers macrophages with critical functions necessary for defending tissues and supporting organ function.

Through rigorous experimentation involving knock-out models where MafB was selectively disabled, the scientists observed that macrophages devoid of this transcription factor failed to complete their maturation process. These immature macrophages exhibited altered morphology, appearing more rounded and less developed compared to their wild-type counterparts expressing MafB, which displayed mature, well-defined shapes. The morphological alterations signify profound deficits in cellular functionality and specialization.

At the molecular level, MafB’s regulatory influence extends to genes implicated in phagocytosis—the cellular process of engulfing and digesting pathogens and cellular debris—and regulatory pathways governing tissue homeostasis. The study revealed that MafB orchestrates the timely activation and repression of these genes, effectively choreographing the macrophage differentiation program and equipping these cells to execute their crucial roles in maintaining internal stability across diverse tissue environments.

Remarkably, this MafB-dependent genetic regulatory circuit was found to be evolutionarily conserved not only between mice and humans but broadly across vertebrate species. Such conservation underscores the integral role of MafB in immune cell biology, reinforcing the concept of a universal developmental blueprint guiding macrophage identity and function regardless of organismal context.

Importantly, the ramifications of MafB deficiency extend beyond isolated immune dysfunction. The impaired macrophage maturation translates into significant physiological consequences, disrupting processes such as iron recycling in the spleen and compromising the function of vital organs including the lungs, intestines, and kidneys. These findings vividly illustrate the systemic impact macrophages exert on overall physiological balance and organ health, further highlighting the transcription factor’s indispensability.

The research pioneers the conceptual framework that macrophages maintain their specialized identity through a shared, genetically encoded program orchestrated by MafB, which operates in tandem with local environmental cues to tailor macrophage phenotypes within different organs. This dual strategy ensures both adaptability and a conserved core functionality essential for organismal homeostasis.

Beyond elucidating fundamental biology, the study’s insights into MafB’s role have profound translational implications. Numerous chronic pathological conditions—ranging from inflammatory disorders and fibrosis to infectious diseases and metabolic syndromes—are characterized by dysfunctional macrophage responses. Targeting MafB or its downstream molecular pathways offers a compelling strategy for restoring macrophage functionality and ameliorating tissue damage across a spectrum of illnesses.

The identification of MafB as a linchpin in macrophage development and function establishes a new paradigm in immunology, revealing how immune cells sustain organ health through tightly regulated genetic programs. This discovery also paves the way for innovative therapeutic designs aimed at modulating macrophage identity in situ, potentially enhancing resilience to chronic diseases that currently pose significant clinical challenges.

The University of Liège team’s work represents a monumental advance by delineating a conserved molecular “switch” essential for immune surveillance and organ homeostasis. It underscores the importance of gene regulatory networks in defining cellular identity and function, offering a refined perspective on the interface between immunity and organ physiology.

As research continues to delve deeper into MafB’s intricate genetic controls, the scientific community anticipates further breakthroughs elucidating how macrophages dynamically integrate signals to maintain tissue health. This foundational study not only enriches our comprehension of immune cell biology but also charts a promising course toward leveraging genetic regulators to fortify human health against immunological and metabolic disorders.

In sum, MafB emerges as a master architect of macrophage identity, essential for their maturation and indispensable for sustaining the multifaceted roles these cells play in protecting and maintaining organ systems. Unraveling this conserved transcriptional program marks a significant milestone with broad implications for immunology, physiology, and regenerative medicine.

Subject of Research: The role of MafB as a conserved transcriptional regulator governing macrophage development, functional identity, and organ homeostasis across tissues and species.

Article Title: MafB is a conserved transcriptional regulator of macrophage development and functional identity across tissues and species

News Publication Date: 26-Feb-2026

Web References:
http://dx.doi.org/10.1016/j.immuni.2026.01.012

Image Credits: University of Liège / Philippe Compère

Keywords: MafB, macrophage maturation, transcription factor, immune regulation, phagocytosis, tissue homeostasis, organ health, gene regulatory network, evolutionary conservation, immunophysiology, chronic diseases, immune cell identity

The investigation began with the isolation and profiling of four distinct B-1 developmental stages: fetal liver B-1 progenitors, adult bone marrow B-1 progenitors, peritoneal cavity B-1 cells, and splenic B-1 cells. By applying trajectory analysis to this comprehensive dataset, researchers discerned a continuous developmental path beginning with fetal liver progenitors and culminating in mature peripheral B-1 cells. Notably, splenic and peritoneal B-1 cells clustered near the mature end of the trajectory, highlighting their advanced differentiation state.

Importantly, a small subset of splenic and peritoneal cavity B-1 cells localized within the fetal liver progenitor cluster, providing compelling evidence for the existence of splenic B-1a precursors. This finding challenges previous paradigms that predominantly situated B-1 progenitors within hepatic or bone marrow niches, underscoring the dynamic nature of B-1a cell ontogeny.

Expression analyses revealed contrasting patterns for Lef1 and Tcf7 (encoding LEF1 and TCF1, respectively). Lef1 was robustly expressed in B-1 progenitors derived from both fetal liver and bone marrow, with expression levels waning in peripheral mature B-1 cells. Conversely, Tcf7 expression was minimal in progenitor populations but escalated significantly in splenic and peritoneal cavity B-1 cells. This reciprocal expression suggests temporally distinct roles for these transcription factors during B-1 cell development.

Further characterization of gene expression patterns elucidated molecules intimately associated with B-1 cell ontogeny. Fetal B-1 progenitors prominently expressed Lin28b, Arid3a, and Il7r, genes previously implicated in lymphoid development and progenitor maintenance. Bone marrow progenitors exhibited elevated Bhlhe41 expression, which intensified in mature splenic and peritoneal B-1 cell populations. Mature B-1 cells also uniquely expressed Ctla4 and Bmi1, genes linked to immune regulation and cellular longevity.

Functional interrogation of signaling pathways illuminated distinct consequences of LEF1 and TCF1 deficiencies. Loss of LEF1 perturbed the IL-6–STAT3, TGFβ, and TNF signaling cascades, pathways integral to inflammation and cellular communication. In contrast, TCF1 deficiency principally disrupted cell cycle processes, notably the regulation of E2F targets and G2–M phase checkpoints, indicating a pivotal role for TCF1 in controlling B-1 cell proliferation. Strikingly, deficiencies in either transcription factor converged on dysregulation of the IL-2–STAT5 signaling pathway, underscoring IL-2 signaling as a shared and essential axis for B-1a cell function.

Reanalysis of a comprehensive human prenatal single-cell atlas revealed parallel expression patterns. Cells expressing classical mouse B-1a markers such as CD5 and SPN (encoding CD43) consistently co-expressed TCF1 and LEF1. Those co-expressing both transcription factors exhibited heightened expression of CD5, SPN, IL2RG, and IL7RA compared to cells expressing either factor alone. This conserved signature implicates TCF1 and LEF1 as crucial regulators not only in mouse but also in human B-1 cell biology.

Intriguingly, human progenitor B cells, including the ProB subset known for proliferative capacity, also expressed TCF1 and LEF1, mirroring observations in mice. This was corroborated by MKI67 expression, a well-established marker of cellular proliferation, which appeared prominently in cycling B cells co-expressing these transcription factors. Such findings align with the concept that TCF1 and LEF1 orchestrate developmental and proliferative programs in early B-lineage cells.

Given the centrality of IL-2 signaling downstream of TCF1 and LEF1, the research investigated B-1-like populations in human patients with severe combined immunodeficiency (SCID) attributed to mutations in IL2RG (IL-2 receptor gamma chain) and IL7RA (IL-7 receptor alpha chain). Remarkably, pediatric patients harboring IL-2Rγ deficiency exhibited an approximate 80% reduction in circulating B-1-like cells compared to healthy controls. This stark reduction underscores the indispensable nature of IL-2Rγ-mediated signaling for human B-1 cell maintenance.

Nonetheless, the authors caution that age disparities between patients (median 6 years) and healthy donors (median 24 years), coupled with evidence that adult mice possess twice as many B-1a cells as their juvenile counterparts, warrant further investigation before definitive causal relationships can be established in humans. Such nuances exemplify the complexity underlying immunological development and phenotypic variation.

This study’s revelations advance our understanding of B-1a cell biology by assigning precise molecular functions to TCF1 and LEF1, illuminating previously uncharted territory in immune regulation. The elucidation of signaling pathways, transcriptional circuits, and developmental trajectories marks a significant leap toward therapeutic manipulation of B-1 cells, which are implicated in immunity against pathogens and in autoimmunity.

Future research avenues may explore how modulation of TCF1 and LEF1 activity influences B-1 cell responses during infections and autoimmune conditions. Additionally, given the parallels between mouse and human systems, therapeutic targeting of IL-2 and IL-7 receptor pathways may hold promise for correcting B-1 cell deficiencies in immunodeficiencies or harnessing their regulatory properties.

In sum, this comprehensive work elegantly integrates developmental immunology, molecular genetics, and single-cell transcriptomics to reveal a finely tuned regulatory network governing B-1a cell homeostasis. The cross-species conservation of these mechanisms highlights the evolutionary significance of TCF1 and LEF1 and their potential as key nodes in immune modulation strategies.

Subject of Research: Roles of transcription factors TCF1 and LEF1 in B-1a cell development, homeostasis, and signaling pathways.

Article Title: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.

Article References:
Shen, Q., Wang, H., Roco, J.A. et al. TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function. Nature (2025). https://doi.org/10.1038/s41586-025-09421-0

Image Credits: AI Generated